Dashboard
Manage Tickers

MNKD MANNKIND CORP

Nasdaq mannkindcorp.com


$ 5.62 $ -0.07 (-1.23 %)    

Friday, 07-Nov-2025 16:06:29 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 5.63
$ 5.60
$ 5.50 x 1,000
$ 5.88 x 100
$ 5.52 - $ 5.67
$ 3.38 - $ 7.48
3,176,488
na
1.73B
$ 1.15
$ 59.14
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-11-2021 06-30-2021 10-Q
19 05-12-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-04-2020 09-30-2020 10-Q
22 08-05-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-16-2017 12-31-2016 10-K
37 11-09-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-15-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mannkind-q3-adj-eps-007-beats-002-estimate-sales-82130m-beat-80255m-estimate
MannKind Q3 Adj. EPS $0.07 Beats $0.02 Est...
11/05/2025 13:05:46

MannKind (NASDAQ:MNKD) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.02 by 233...

earnings-scheduled-for-november-5-2025
Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

fda-accepts-for-review-mannkinds-supplemental-biologics-license-application-for-inhaled-insulin-in-children-4-17-years
FDA Accepts For Review MannKind's Suppleme...
10/13/2025 12:10:02

hc-wainwright--co-reiterates-buy-on-mannkind-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Mann...
10/13/2025 11:12:42

HC Wainwright & Co. analyst Brandon Folkes reiterates MannKind (NASDAQ:MNKD) with a Buy and maintains $11 price target.

hc-wainwright--co-reiterates-buy-on-mannkind-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Mann...
09/18/2025 10:17:42

HC Wainwright & Co. analyst Brandon Folkes reiterates MannKind (NASDAQ:MNKD) with a Buy and maintains $11 price target.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
09/09/2025 17:35:29

oppenheimer-maintains-outperform-on-mannkind-raises-price-target-to-15
Oppenheimer Maintains Outperform on MannKi...
09/05/2025 14:31:27

Oppenheimer analyst Andreas Argyrides maintains MannKind (NASDAQ:MNKD) with a Outperform and raises the price target from $1...

wells-fargo-maintains-overweight-on-mannkind-raises-price-target-to-10
Wells Fargo Maintains Overweight on MannKi...
09/03/2025 12:58:45

Wells Fargo analyst Tiago Fauth maintains MannKind (NASDAQ:MNKD) with a Overweight and raises the price target from $9 to $10.

hc-wainwright--co-maintains-buy-on-mannkind-raises-price-target-to-11
HC Wainwright & Co. Maintains Buy on MannK...
09/02/2025 16:16:43

HC Wainwright & Co. analyst Brandon Folkes maintains MannKind (NASDAQ:MNKD) with a Buy and raises the price target from ...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 12:08:23

Core News & Articles
United Therapeutics Expands MannKind Deal ...
08/27/2025 12:08:54

 MannKind Corporation (NASDAQ:MNKD) today announced that United Therapeutics Corporation (NASDAQ:UTHR) has exercised its option...

rbc-capital-maintains-outperform-on-mannkind-raises-price-target-to-8
RBC Capital Maintains Outperform on MannKi...
08/26/2025 14:21:58

RBC Capital analyst Douglas Miehm maintains MannKind (NASDAQ:MNKD) with a Outperform and raises the price target from $7 to $8.

mannkind-backed-by-blackstone-expands-cardiorenal-focus-with-360-million-deal
MannKind, Backed By Blackstone, Expands Ca...
08/25/2025 17:57:32

MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a ...

hc-wainwright--co-reiterates-buy-on-mannkind-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Mann...
08/25/2025 17:54:17

HC Wainwright & Co. analyst Brandon Folkes reiterates MannKind (NASDAQ:MNKD) with a Buy and maintains $9 price target.

Core News & Articles
MannKind To Acquire scPharmaceuticals For ...
08/25/2025 11:33:57

rbc-capital-maintains-outperform-on-mannkind-lowers-price-target-to-7
RBC Capital Maintains Outperform on MannKi...
08/07/2025 15:06:29

RBC Capital analyst Douglas Miehm maintains MannKind (NASDAQ:MNKD) with a Outperform and lowers the price target from $8 to $7.

mannkind-q2-2025-adj-eps-005-inline-sales-76527m-miss-77521m-estimate
MannKind Q2 2025 Adj. EPS $0.05, Inline, S...
08/06/2025 12:07:10

mannkind-secures-up-to-500m-from-blackstone-to-fuel-afrezza-launch-and-pipeline-growth-without-diluting-shareholders
MannKind Secures Up to $500M From Blacksto...
08/06/2025 11:12:43

MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products ...

mannkind-and-blackstone-announced-an-500m-strategic-financing-agreement-the-financing-agreement-provides-mannkind-with-non-dilutive-capital-to-advance-its-short--and-long-term-growth-strategies
MannKind And Blackstone Announced An $500M...
08/06/2025 11:12:11

The up to $500 million senior secured credit facility consists of a $75 million initial term loan funded at closing, a $125 mil...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION